Form 8-K - Current report:
SEC Accession No. 0001104659-25-016134
Filing Date
2025-02-21
Accepted
2025-02-21 16:07:41
Documents
14
Period of Report
2025-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257286d1_8k.htm   iXBRL 8-K 32612
2 EXHIBIT 10.1 tm257286d1_ex10-1.htm EX-10.1 94537
  Complete submission text file 0001104659-25-016134.txt   322487

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alms-20250218.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20250218_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alms-20250218_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT tm257286d1_8k_htm.xml XML 3679
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42143 | Film No.: 25651903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)